Form D · Manufacturing

BIOSYNTHETIC TECHNOLOGIES, LLC

Irvine, CA · CIK 0001577689

Offering snapshot reported Feb 7, 2017 · SEC filing

Reported sold: $16.5M
Investors reported: 5
Minimum accepted: $0
First sale: Dec 27, 2016

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$10,000,000 → $16,506,797
Reported investors1 → 5

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Feb 7, 2017	Amendment	$16,506,797	$6,506,797vs Jan 10, 2017	5	SEC filing
Jan 10, 2017	Initial	$10,000,000	No comparison	1	SEC filing
Oct 2, 2014	Initial	$12,000,000	No comparison	3	SEC filing
Aug 8, 2013	Initial	$9,000,000	No comparison	1	SEC filing
May 24, 2013	Initial	$14,736,715	No comparison	13	SEC filing

Offering details

Securities: Debt
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-278003

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
None	None

Source: Form D, filed Feb 7, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Allen Barbieri	Director, Executive
Steve Bierschenk	Director
Steven Bierschenk	Director
John Hopkins	Director
Gerald Kohlenberger	Director
Bernhard Mohr	Director
Meghan Sharp	Director
Kent Wasson	Director

Issuer details

Industry: Manufacturing (See others in industry)

Address:

2 Park Plaza Suite 200
Irvine, CA, 92614